Biochemistry Quiz: Experimental Design Controls Replicates And Confounds

What this quiz covers

This quiz focuses on Experimental Design Controls Replicates And Confounds, giving you a quick way to practice the rules, question types, and explanations that matter most for Biochemistry.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

Question 1

1. Cells cultured with an equivalent volume of DMSO added to the medium. (correct answer)
2. Cells cultured in medium with no additions.
3. Cells treated with a structurally similar but biologically inactive analog of the drug.
4. Cells in which the target kinase has been genetically knocked out, then treated with the drug.

Explanation: When a substance (like a drug) is dissolved in a solvent (vehicle) for delivery, it is crucial to test for effects of the vehicle alone. DMSO is known to have biological effects on its own. Therefore, a 'vehicle control' (A) where cells are treated with just DMSO is essential to ensure that the observed phosphorylation is a result of the drug, not its solvent. Untreated cells (B) are a baseline but don't control for DMSO. An inactive analog (C) is an excellent control for specificity, but the vehicle control is more fundamental. A knockout (D) helps identify the drug's target but does not address the solvent issue.

Question 2

1. Perform a dose-response analysis to determine the EC50 of Adrenaline for the glycogenolysis effect.
2. Measure the concentration of cAMP, the second messenger downstream of the receptor, after Adrenaline treatment.
3. Repeat the experiment using cells pre-treated with a potent, specific antagonist of the β-adrenergic receptor before adding Adrenaline. (correct answer)
4. Treat the cells with a different hormone, such as insulin, to demonstrate that the cellular machinery for regulating glycogenolysis is intact.

Explanation: When you encounter questions about proving a specific receptor's role in a biological response, you need to think about experimental controls and the most direct way to establish causation. The correct approach is C because using a specific β-adrenergic receptor antagonist provides the most direct test of whether this particular receptor mediates the effect. If you block the receptor with an antagonist and the adrenaline-induced glycogenolysis is prevented or significantly reduced, you've directly demonstrated that this specific receptor is required for the response. This is a classic pharmacological approach that isolates the variable you're testing. A is incorrect because a dose-response curve only tells you about the potency and efficacy of adrenaline, not which specific receptor mediates the effect. Adrenaline could theoretically work through other receptors at different concentrations. B is wrong because measuring cAMP only confirms that the known signaling pathway is active, but doesn't prove that the β-adrenergic receptor specifically is required. Other receptors could also activate adenylyl cyclase and increase cAMP. D is incorrect because testing insulin merely shows that the glycogen metabolism machinery works bidirectionally (insulin promotes glycogen synthesis), but provides no information about which receptor mediates adrenaline's effects. Key strategy: In receptor pharmacology questions, look for experiments using specific antagonists or receptor knockouts—these provide the most direct evidence for a receptor's necessity in a particular response. Control experiments should isolate the single variable being tested.

Question 3

1. The acidic conditions could damage the cell membrane, leading to a non-specific release of lactate and other metabolites.
2. Lactate is an acid, and its increased production would naturally cause the observed drop in pH, creating a feedback loop.
3. The drug may not be able to enter the cell effectively at the lower extracellular pH, altering its effective concentration.
4. The activity of key glycolytic enzymes, such as phosphofructokinase-1, is highly sensitive to pH, and the pH drop itself could alter the pathway's flux. (correct answer)

Explanation: When analyzing experimental results involving metabolic pathways, you must always consider whether observed effects are due to the drug itself or to changes in experimental conditions. This question tests your understanding of how environmental factors can confound biochemical experiments. The correct answer is D because phosphofructokinase-1 (PFK-1), the rate-limiting enzyme of glycolysis, is exquisitely sensitive to pH changes. PFK-1 activity increases significantly as pH drops from 7.4 to 6.9, which would directly stimulate glycolytic flux and increase lactate production. This pH effect alone could explain the results without any direct drug action on glycolytic enzymes, making the investigator's conclusion premature. Option A is incorrect because while membrane damage could release intracellular lactate, a pH drop from 7.4 to 6.9 is relatively modest and unlikely to cause significant membrane disruption in cultured cells. Option B reverses cause and effect – the pH drop occurred immediately upon drug addition (before significant lactate could accumulate), so the acidification caused increased lactate production, not vice versa. Option C incorrectly suggests reduced drug uptake at lower pH would be problematic, but this would decrease, not increase, any drug effect on lactate production. The key lesson: always consider whether changes in experimental conditions (pH, temperature, ionic strength) could independently affect the biological system you're studying. In metabolic experiments, pH effects on enzyme activity are particularly important confounding variables to control for.

Question 4

1. The total amount of RNA extracted from the Starved culture was likely lower than from the Fed culture.
2. The pH of the Starved medium may have changed differently than the Fed medium over 48 hours.
3. The qPCR primers used for Gene P might have different efficiencies in the two sample types.
4. The two cell cultures have likely reached different stages of the cell growth cycle or density. (correct answer)

Explanation: When evaluating gene expression experiments, you must consider all variables that could influence your results beyond your intended experimental condition. This question tests your ability to identify the most significant confounding factor in a controlled experiment. The correct answer is D because cell growth stage and density dramatically affect gene expression patterns. After 48 hours, the Fed culture likely reached stationary phase with high cell density, while the Starved culture remained in an earlier growth phase with lower density. Different growth phases trigger distinct transcriptional programs - many genes are naturally upregulated during slower growth or stress conditions, which could easily account for the five-fold increase in Gene P expression independent of the nutrient depletion hypothesis. Option A is incorrect because lower total RNA extraction doesn't affect qPCR results when properly normalized. qPCR measures relative gene expression ratios, not absolute RNA amounts. Option B, while pH changes can affect gene expression, is much less likely to cause such a dramatic and specific five-fold increase compared to the profound effects of growth phase differences. Option C is wrong because qPCR primer efficiency would be determined by the target sequence itself, not the sample type - the same Gene P sequence exists in both cultures. Remember that in gene expression studies, growth phase is one of the most powerful variables affecting transcription. Always consider whether compared samples are at equivalent growth stages and cell densities. This is why proper experimental design includes growth curve analysis and standardized harvest timepoints.

Question 5

1. A reaction containing lactase and lactose in the same buffer, but without Inhibitor X. (correct answer)
2. A solution containing lactose and Inhibitor X in the same buffer, but without lactase.
3. A solution containing only lactase and Inhibitor X in the same buffer.
4. A reaction containing lactase, lactose, and a known, potent lactase inhibitor instead of Inhibitor X.

Explanation: To claim that a compound inhibits an enzyme, one must first establish the enzyme's baseline activity under the same conditions but in the absence of the inhibitor. This 'no inhibitor' control (A) provides the reference rate to which the inhibited rate is compared. Choice (B) is a control for non-enzymatic substrate breakdown, which is useful but not as critical as the baseline activity. Choice (C) contains no substrate and thus would show no reaction, providing no useful rate information. Choice (D) is a positive control, which demonstrates that inhibition can be detected in the assay, but it doesn't help determine if Inhibitor X itself is effective.

Question 6

1. A competition assay including TF-A, radiolabeled Seq-X, and a large excess of unlabeled Seq-X. (correct answer)
2. An assay containing TF-A and radiolabeled Seq-X performed at a higher salt concentration.
3. An assay incubating a different, unrelated protein with radiolabeled Seq-X.
4. A competition assay including TF-A, radiolabeled Seq-X, and a large excess of unlabeled, non-specific DNA.

Explanation: To demonstrate specificity, one must show that the interaction can be specifically competed away. Adding a large excess of unlabeled, 'cold' specific competitor (unlabeled Seq-X) should cause a decrease in the shifted radiolabeled band, as the labeled and unlabeled DNA compete for the same binding site on TF-A. While a non-specific DNA competitor (D) is also a very important control to show the protein doesn't bind just any DNA, the specific competitor (A) is the most direct test of the specific interaction with Seq-X. Higher salt (B) tests interaction strength, not sequence specificity. Using another protein (C) tests the uniqueness of TF-A, not its sequence preference.

Question 7

1. The measurement of ATP production rate for that specific mitochondrial preparation is precise. (correct answer)
2. The observed ATP production rate is representative of all mice of that species and strain.
3. The assay used to measure ATP production is guaranteed to be free of systematic errors.
4. The single mouse from which the sample was taken has a normal metabolic phenotype.

Explanation: Technical replicates involve repeated measurements of the same sample to assess the variability of the measurement technique itself. Consistent results from technical replicates indicate high precision (low random error) for the assay on that particular sample. However, this says nothing about biological variability between different individuals, which would require biological replicates (isolating mitochondria from multiple different mice) (B). Precision does not guarantee accuracy, as there could be a consistent systematic error (C). Without comparison to a population of mice, no conclusion about normalcy can be made (D).

Question 8

1. Growth Factor Z might activate Enzyme B through a separate signaling pathway that is independent of the Molecule A concentration increase. (correct answer)
2. The assay used to measure the activity of Enzyme B might have been influenced by the presence of Growth Factor Z in the cell lysate.
3. The increase in Molecule A concentration may have occurred after the increase in Enzyme B activity, reversing the proposed causality.
4. The observed increase in Enzyme B activity might be within the normal range of biological variability for these cells.

Explanation: Correlation does not equal causation. The observation that A and B both increase after a single stimulus (Growth Factor Z) does not prove that A causes the increase in B. It is entirely possible that the growth factor initiates two parallel, independent signaling cascades: one that leads to more Molecule A, and another that activates Enzyme B. This is a classic 'third variable' problem where the growth factor is the third variable causing both effects. To establish causality, one would need to manipulate Molecule A directly and observe the effect on Enzyme B. The other options describe issues of technical artifact (B), temporality (C), or statistical significance (D), but (A) addresses the core logical flaw in the causal inference.

Question 9

1. The experiment fails to include a control protein from an unrelated organism to calibrate the heat denaturation process.
2. Testing five aliquots is insufficient to achieve statistical significance for the observed difference in stability.
3. The temperature of 50°C may not be physiologically relevant, so the results may not apply in vivo.
4. The use of a single purification batch for each protein type means any observed difference could be due to a batch-specific artifact rather than the mutation itself. (correct answer)

Explanation: When evaluating experimental design in biochemistry, you must always consider whether the observed results truly reflect the biological phenomenon being studied or could be explained by experimental artifacts. This question tests your ability to identify confounding variables that could invalidate conclusions. The major flaw here is that each protein type was prepared as a single batch, then divided into aliquots for testing. Even though five aliquots were tested from each batch, all the mutant samples came from one preparation and all the wild-type samples came from another preparation. Any difference in thermal stability could therefore result from batch-to-batch variation in the purification process rather than the mutation itself. Perhaps the mutant batch had slightly different buffer conditions, protein concentration, or contaminating proteases that affected stability. Answer D correctly identifies this critical design flaw. Let's examine why the other options miss the mark: Answer A is incorrect because control proteins from other organisms aren't necessary to compare two versions of the same enzyme. Answer B misunderstands statistics—the issue isn't sample size but rather that the samples aren't truly independent since they come from single batches. Answer C raises a valid scientific question about physiological relevance, but this doesn't represent a fundamental experimental design flaw that would invalidate the conclusion about relative stability differences. Study tip: In protein biochemistry experiments, always look for proper controls and replication. True biological replicates require independent preparations (multiple batches), not just multiple measurements from the same preparation (technical replicates). This distinction frequently appears on biochemistry exams.

Question 10

1. The exact protein concentration of the WT and MT samples used for the heat treatment.
2. The concentration of the substrate used in the activity assay.
3. The specific activity of each enzyme (e.g., in U/mg) at time zero under standard assay conditions. (correct answer)
4. The melting temperature (Tm) of both proteins as determined by differential scanning calorimetry.

Explanation: When evaluating enzyme stability experiments, you must distinguish between measuring enzyme degradation versus measuring enzyme activity changes. This question tests whether you understand what controls are necessary to draw valid conclusions about protein stability. The correct answer is C because specific activity (units of activity per mg of protein) tells you how much active enzyme you're starting with in each sample. Without knowing the initial specific activities, you can't determine whether the mutant's greater activity loss is due to thermal instability or simply because it started with lower activity. For example, if the wild-type has 100 U/mg and the mutant has 20 U/mg at time zero, both at the same protein concentration, then comparing percentage activity loss becomes meaningless—you're comparing apples to oranges. Option A is incorrect because equal protein concentrations don't ensure equal amounts of active enzyme if the proteins have different specific activities. Option B is wrong because substrate concentration affects the absolute activity readings but wouldn't differentially impact the comparison between wild-type and mutant if both are assayed under identical conditions. Option D, while scientifically valuable, isn't the most significant confound here—you can observe stability differences without knowing melting temperatures, but you cannot interpret activity loss data without knowing baseline specific activities. Study tip: In enzyme stability experiments, always ensure you're comparing equivalent amounts of active enzyme at the start. Protein concentration alone isn't sufficient—you need activity per unit protein to make valid comparisons.

Question 11

1. The fractions from the observed peak must be collected and analyzed by SDS-PAGE to confirm the presence of both X and Y.
2. The column must be calibrated with a series of known molecular weight standards.
3. Each protein, X and Y, must be run individually on the same column under identical conditions. (correct answer)
4. The experiment should be repeated with a non-interacting protein Z mixed with protein X.

Explanation: When evaluating protein-protein interactions using size-exclusion chromatography, you're separating molecules based on their size - larger complexes elute earlier than smaller individual proteins. The key principle is that if two proteins interact, their combined molecular weight should produce a peak at a different elution volume than either protein alone. The researcher observed a single peak at higher molecular weight, suggesting complex formation. However, without running proteins X and Y individually under identical conditions, you cannot definitively conclude they're interacting. The individual runs establish the baseline elution volumes for each protein alone, allowing you to compare these to the mixed sample. Only then can you determine if the observed peak truly represents a complex or if one protein naturally elutes at that position. Option A is useful but secondary - SDS-PAGE analysis would confirm both proteins are present in the peak, but doesn't address the fundamental control issue. Option B assumes the column isn't already calibrated, which is typically done during setup and isn't the missing experimental control. Option D suggests adding a non-interacting protein, which could provide additional evidence but isn't essential for interpreting the basic result. The individual protein runs in option C provide the critical reference points that make the data interpretable. Without knowing where X and Y elute separately, you cannot conclude that the observed peak represents an interaction. Study tip: In protein interaction experiments, always ask "What are the appropriate controls?" Individual component runs are essential baselines for any binding or interaction assay.

Question 12

1. The compound is unstable and degrades during the course of the assay.
2. The compound directly quenches the fluorescence of the liberated fluorophore. (correct answer)
3. The compound binds to the uncleaved peptide substrate, making it inaccessible to the enzyme.
4. The compound precipitates out of the solution, reducing its effective concentration.

Explanation: When evaluating enzyme assays, you need to distinguish between true inhibition and experimental artifacts that can mimic inhibition. This fluorescence-based protease assay relies on measuring increased fluorescence as the readout for enzyme activity, making it vulnerable to compounds that interfere with the fluorescence signal itself. The key insight is that if a compound directly quenches the fluorescence of the liberated fluorophore (option B), it would prevent the fluorescence increase even though the protease is still actively cleaving the peptide. The enzyme would be working normally, but you wouldn't detect its activity because the fluorescent signal is being suppressed. This creates a false positive result for inhibition—you'd conclude the compound inhibits the protease when it actually just interferes with your detection method. Option A is wrong because compound degradation would typically reduce any inhibitory effect over time, not maintain it throughout the assay. Option C describes competitive inhibition by substrate sequestration, which would actually be a legitimate mechanism of inhibition, not an artifact. Option D is incorrect because precipitation would reduce the compound's effective concentration, potentially decreasing rather than increasing any inhibitory effects. The critical distinction here is between compounds that affect the enzyme itself versus those that interfere with your assay readout. True enzyme inhibitors modify the enzyme's catalytic activity, while artifacts like fluorescence quenching give misleading results without affecting the actual biochemical reaction. Study tip: In any enzyme assay question, always consider whether the compound affects the enzyme directly or interferes with the detection method—this separation helps identify potential artifacts.

Question 13

1. A non-allosteric, noncompetitive inhibitor that binds equally well to the free enzyme and the enzyme-substrate complex would produce the identical kinetic pattern. (correct answer)
2. The experiment does not rule out the possibility that Molecule Z is an uncompetitive inhibitor.
3. The kinetic data only show correlation, and Molecule Z could be indirectly causing the effect by modifying a required cofactor in the solution.
4. The observed change in Vmax could be an artifact if Molecule Z absorbs light at the same wavelength used to monitor the reaction.

Explanation: This question highlights the distinction between a kinetic description ('noncompetitive inhibition') and a structural mechanism ('allosteric inhibition'). The kinetic pattern of decreased Vmax with no change in Km defines noncompetitive inhibition. While many allosteric inhibitors exhibit this pattern, it is not proof of an allosteric mechanism. A classical noncompetitive inhibitor could, in theory, bind somewhere in or near the active site (not an allosteric site) in such a way that it prevents catalysis but doesn't affect substrate binding. Thus, kinetics alone cannot distinguish these structural possibilities. Uncompetitive inhibition (B) has a different kinetic signature (decreased Vmax and Km). While (C) and (D) are possible issues, (A) points out the fundamental limitation in equating a kinetic pattern with a specific structural mechanism.

Question 14

1. A positive control lane containing purified protein P should be included to confirm antibody specificity.
2. The blot must be stripped and re-probed with an antibody for a loading control protein, like actin or tubulin, to normalize the data. (correct answer)
3. The experiment must be repeated using a different primary antibody for protein P to ensure the effect is not an antibody artifact.
4. The protein concentration of the cell lysates should be measured before loading, for example by a Bradford assay.

Explanation: When analyzing Western blot results, the fundamental principle is that you're comparing relative protein amounts between samples. However, experimental variables like pipetting errors, cell counting mistakes, or differences in cell lysis efficiency can create misleading results that have nothing to do with actual protein expression changes. Option B is correct because loading control normalization is essential for valid quantitative comparisons. Even if you see a darker band for protein P in the treated lane, this could simply mean you loaded more total protein in that lane. By stripping the blot and re-probing with an antibody against a housekeeping protein (like actin or tubulin), you can normalize your protein P signal to the amount of total cellular protein actually loaded. Only after this normalization can you confidently conclude that protein P levels per cell have truly increased. Option A addresses antibody specificity, which is important for confirming you're detecting the right protein, but doesn't solve the quantification problem. Option C suggests using a different antibody, which could help verify results but again doesn't address the core issue of loading variability. Option D mentions measuring protein concentration before loading, which is good practice, but measuring and actually loading equal amounts are different things—pipetting errors and other variables can still create unequal loading. Remember: In any quantitative Western blot experiment, loading controls are your safety net. Without proper normalization, even dramatic band intensity differences could be experimental artifacts rather than real biological changes.

Question 15

1. Social stress from aggressive cage-mates could alter the metabolism of the WT mice, making the comparison invalid.
2. Increased physical activity would independently increase the demand for energy, thereby stimulating fatty acid oxidation, regardless of the transgene's direct effect. (correct answer)
3. The transgenic mice may consume more food due to their higher activity, leading to altered substrate availability for oxidation.
4. The stress of handling the aggressive transgenic mice could have introduced measurement errors by the experimenters.

Explanation: When evaluating experimental results, you must always consider confounding variables—factors that could influence your outcome independently of the variable you're actually testing. In metabolic studies, behavioral differences can be major confounders because behavior directly affects energy demand. The key insight here is that increased physical activity creates an independent metabolic demand. When the transgenic mice are more active and aggressive, their muscles require more ATP to fuel movement and behavioral responses. This increased energy demand naturally stimulates fatty acid oxidation through normal metabolic pathways, regardless of what the overexpressed enzyme might be doing. You can't determine whether the higher oxidation rate comes from the transgene's direct biochemical effect or simply from the mice needing more energy for their hyperactive behavior. This makes option B correct. Looking at the distractors: Option A focuses on stress affecting the wild-type mice, but the confounding issue is with interpreting the transgenic mice's results, not problems with the control group. Option C suggests altered food consumption, but this doesn't address the core issue—even with identical food intake, more active mice would still oxidize more fatty acids to meet their energy demands. Option D mentions measurement errors from handling difficulties, but this is about technical issues rather than the biological confounding that makes the results uninterpretable. Remember: in biochemistry experiments, always ask whether behavioral, environmental, or physiological differences could independently affect the metabolic pathway you're studying. Activity level is one of the strongest confounders in metabolic research.

Question 16

1. Test whether the metabolite affects the activity of a structurally unrelated enzyme in the same cell extract to determine specificity of the regulatory effect
2. Incubate the purified target enzyme (isolated from the cell extract) with the metabolite under identical conditions to verify direct enzyme-metabolite interaction (correct answer)
3. Pre-incubate the metabolite alone under the experimental conditions, then test whether degradation products rather than the original metabolite cause the observed inhibition
4. Measure enzyme activity immediately after metabolite addition (time zero) rather than after 2 hours to distinguish direct inhibition from time-dependent indirect effects

Explanation: Testing the purified enzyme (B) is most critical because cell extracts contain numerous proteins that could mediate indirect effects. The metabolite might regulate the target enzyme indirectly through kinases, phosphatases, or other regulatory proteins present in the extract. Only by testing the isolated enzyme can researchers determine if the regulation is direct. Choice A tests specificity but doesn't address direct vs. indirect mechanisms. Choice C considers metabolite stability, which is important but secondary to the direct/indirect question. Choice D addresses kinetics but time-dependent effects don't necessarily indicate indirect regulation.

Question 17

1. Include biological replicates from both control and treated conditions on each experimental day, then perform statistical analysis to separate day effects from treatment effects
2. Prepare and analyze technical replicates (multiple injections of the same sample extract) to assess the precision of the analytical measurement process
3. Randomize the order of sample analysis within each day and use internal standards added to each sample to normalize for extraction and detection efficiency
4. Run a pooled quality control sample (mixture of all samples) at regular intervals throughout each analytical batch to monitor instrument performance and signal drift (correct answer)

Explanation: When analyzing metabolomics data with day-to-day variation, you need to distinguish between true biological effects and systematic analytical drift that affects all samples similarly over time. This is a classic quality control challenge in analytical chemistry. Option D is correct because pooled quality control (QC) samples contain the same mixture of metabolites run repeatedly throughout each batch. If the apparent increases in treated samples are due to instrument drift, sensitivity changes, or other analytical artifacts, you'll see the same pattern of increase in the pooled QC samples over time. Since the pooled QC has a constant composition, any changes in signal must be analytical artifacts. If the QC samples remain stable while treated samples show increases, then the treatment effect is likely real. Option A addresses experimental design for biological variation but won't identify analytical artifacts that affect all samples on a given day equally. Option B focuses on injection precision, which measures short-term reproducibility but won't detect the systematic day-to-day drift described in the question. Option C helps with sample-to-sample normalization and reduces bias from analysis order, but internal standards added to individual samples won't reveal instrument-wide performance changes over days. For metabolomics troubleshooting, remember that pooled QC samples are your best tool for detecting systematic analytical problems because they provide a constant biological matrix to monitor instrument performance over time. Look for parallel trends between your samples of interest and the QC samples to identify analytical artifacts.

Question 18

1. A condition with mitochondria + ADP + Pi + vehicle control (solvent without inhibitor) to account for potential solvent effects on oxygen consumption (correct answer)
2. A condition with heat-inactivated mitochondria + inhibitor to verify that the inhibitor does not chemically consume oxygen independently
3. A condition with mitochondria + substrate (succinate or malate) to ensure the electron transport chain is properly functioning
4. A condition with mitochondria + uncoupler (FCCP) to demonstrate maximal possible oxygen consumption by these mitochondria

Explanation: The most critical missing control is the vehicle control (A). Since inhibitors are typically dissolved in solvents like DMSO or ethanol, it's essential to test whether the solvent itself affects oxygen consumption. Without this control, any observed inhibition could be due to the solvent rather than the inhibitor compound. Choice B tests inhibitor specificity but is less critical since chemical oxygen consumption would be obvious. Choice C provides a positive control for electron transport function but isn't addressing a potential confound. Choice D shows maximal capacity but doesn't control for confounding variables.

Question 19

1. Generate additional mutations at position 127 (Asp→Glu, Asp→Asn) to determine whether the loss of negative charge specifically or any amino acid change at this position reduces activity
2. Measure the thermal stability and CD spectrum of both wild-type and mutant proteins to ensure that the mutation does not cause global protein misfolding (correct answer)
3. Perform enzyme kinetics analysis to determine whether the mutation affects $K_m$, $V_{max}$, or both, providing insight into whether binding or catalysis is impaired
4. Express and purify both proteins under identical conditions and verify equal protein concentrations using Bradford assay to ensure the activity difference reflects specific activity, not protein amount

Explanation: The strongest evidence comes from verifying protein folding integrity (B). If the Asp127Ala mutation causes protein misfolding, the reduced activity would be an indirect effect rather than evidence that Asp127 is specifically involved in catalysis. CD spectroscopy and thermal stability measurements can reveal if the protein maintains proper secondary/tertiary structure. Choice A provides useful information about charge requirements but doesn't address the fundamental question of whether the protein is properly folded. Choice C gives mechanistic details but assumes the protein is folded correctly. Choice D addresses protein concentration but not structural integrity.

Question 20

1. Implement a standardized cell preparation protocol including specific culture conditions, passage numbers, and membrane patch selection criteria to reduce biological variability between experiments (correct answer)
2. Use the same electrode and recording setup for all experiments, with each student performing measurements on the same day to eliminate equipment-related variability
3. Include a positive control compound (known channel activator) in each experimental session to normalize the data and account for day-to-day variations in experimental conditions
4. Increase the number of channel recordings per condition from the current 5-8 patches to at least 20 patches to improve statistical power and reduce sampling error

Explanation: Standardized cell preparation protocols (A) address the most likely source of variability in patch-clamp experiments. Factors like cell passage number, culture density, membrane health, and patch selection criteria dramatically affect baseline channel properties. Standardization reduces biological and technical variability between experimenters. Choice B addresses equipment variability but is impractical for routine experiments and doesn't solve the fundamental reproducibility issue. Choice C helps with data normalization but doesn't eliminate the underlying variability. Choice D increases statistical power but doesn't address the root cause of inter-experimenter differences.